Charles Ornstein, ProPublica

The federal government has proposed requiring that accreditors release reports on the problems they find during hospital inspections. Right now, the reports are secret.

A review of more than 200 such communications by ProPublica and its partners found dozens of errors and mischaracterizations.

Dr. Suha Abushamma's flight back to Saudi Arabia took off minutes before a federal judge ordered such forced removals to stop.

Dallas Mavericks owner says patients need more testing, even when they aren't sick, a position medical experts say can do more harm than good.

Expenditures could mean higher deductibles and maximum out-of-pocket costs for many of the program's 39 million seniors and disabled enrollees.

Federal overseers have seldom penalized the healthcare organizations responsible for safeguarding this data, a ProPublica review shows.

Some of the nation's largest pharmaceutical companies have slashed payments to health professionals for promotional speeches amid heightened public scrutiny of such spending.

In a major departure from industry practice, GlaxoSmithKline, the sixth-largest global drug maker, announced Tuesday that it will no longer hire doctors to promote its drugs and will stop tying compensation for sales representatives to the number of prescriptions written for drugs they market.